US equities |
SPCX $159.31 ▲+7.79% META $697.52 ▲+0.47% NVDA $221.97 ▲+2.54% MU $913.67 ▲+1.96% TSLA $386.47 ▲+3.41% AAPL $343.99 ▲+1.32% AMD $552.72 ▲+3.36% GOOGL $334.76 ▼-1.62%
FinancialContent

Articles published by Kardium Inc.

News headline image
Kardium Announces First Patient Enrollment in the Globe Registry, Expanding Real-World Evidence for the Globe® Pulsed Field System Following Strong Early Commercial Experience
From Kardium Inc.
Via Business Wire
News headline image
Kardium Launches the “Globe Durability Guarantee”™ – Highlighting the Outstanding Durability of the Globe® System
From Kardium Inc.
Via Business Wire
News headline image
Kardium Receives Health Canada Approval for the Globe® Pulsed Field System
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces Publication of PULSAR Pivotal Trial Results in JACC
From Kardium Inc.
Via Business Wire
News headline image
Kardium receives FDA approval of the Globe® Pulsed Field System
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces $250M (CA$340M) Financing to Launch Innovative Atrial Fibrillation Treatment
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe® PF System
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment
From Kardium Inc.
Via Business Wire
News headline image
Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces Enhanced Clinical Capabilities of the Globe® System With Right Atrial Ablation and Hybrid Energy Ablation
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
From Kardium Inc.
Via Business Wire
News headline image
Kardium Announces First Patients Treated in PULSAR IDE Study of Globe® Pulsed Field System
From Kardium Inc.
Via Business Wire
News headline image
Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System
From Kardium Inc.
Via Business Wire
News headline image
Kardium’s Globe System Begins Clinical Trial at St. Paul's Hospital
From Kardium Inc.
Via Business Wire
News headline image
First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System
From Kardium Inc.
Via Business Wire